Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis

Medicine and Dentistry

• Hip 5%
• Hip Osteoarthritis 5%
• Joint 5%
• Knee 5%
• Knee Osteoarthritis 5%
• Odds Ratio 5%
• Osteoarthritis 15%
• Pain 70%
• Patient 100%
• Pooled Analysis 5%
• Rheumatology 5%
• Subcutaneous Injection 5%
• Symptom 25%
• Tanezumab 20%
• Western Ontario and McMaster Universities Osteoarthritis Index 50%

Nursing and Health Professions

• Hip Osteoarthritis 5%
• Inpatient 10%
• Knee Osteoarthritis 5%
• Odds Ratio 5%
• Osteoarthritis 15%
• Pain 70%
• Placebo 15%
• Procedures 5%
• Subcutaneous Injection 5%
• Symptom 25%
• Tanezumab 20%
• Western Ontario and McMaster Universities Osteoarthritis Index 50%

INIS

• administration 5%
• bone joints 10%
• comparative evaluations 5%
• data 5%
• information 5%
• ontario 5%
• pain 70%
• patients 55%
• populations 5%
• symptoms 25%
• universities 5%